Cargando…
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
BACKGROUND: Clozapine is the treatment of choice in refractory psychosis. In most countries, clozapine must be stopped indefinitely if white blood cells fall below a defined threshold during routine monitoring. Despite evidence of severe adverse consequences of clozapine discontinuation, published a...
Autores principales: | Oloyede, Ebenezer, Dunnett, Danielle, Taylor, David, Clark, Ivana, MacCabe, James H, Whiskey, Eromona, Onwumere, Juliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249299/ https://www.ncbi.nlm.nih.gov/pubmed/37291505 http://dx.doi.org/10.1186/s12888-023-04902-w |
Ejemplares similares
-
Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022) -
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
por: Oloyede, Ebenezer, et al.
Publicado: (2022) -
Management of clozapine treatment during the COVID-19
pandemic
por: Gee, Siobhan, et al.
Publicado: (2020) -
Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
por: Taylor, David, et al.
Publicado: (2022) -
Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study
por: Oloyede, Ebenezer, et al.
Publicado: (2023)